When and How to Treat Relapsed Multiple Myeloma

  • Nathwani N
  • Bertamini L
  • Banerjee R
  • et al.
N/ACitations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

The treatment landscape for relapsed multiple myeloma has expanded considerably in recent years, as numerous agents with new mechanisms of action have been introduced, increasing responses even in advanced disease and prolonging survival. The wealth of novel regimens comes with the challenges of balancing toxicities and aligning a regimen with the biology of the myeloma and the nature of the relapse in conjunction with patient treatment history and personal preference. Herein, we provide an overview of treatment options for both early and late relapsing disease as well as a discussion of the role of emerging immune-based therapies.

Cite

CITATION STYLE

APA

Nathwani, N., Bertamini, L., Banerjee, R., Gay, F., Shah, N., & Krishnan, A. (2021). When and How to Treat Relapsed Multiple Myeloma. American Society of Clinical Oncology Educational Book, (41), 358–375. https://doi.org/10.1200/edbk_320129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free